Correlation Between Tempest Therapeutics and Aerovate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tempest Therapeutics and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tempest Therapeutics and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tempest Therapeutics and Aerovate Therapeutics, you can compare the effects of market volatilities on Tempest Therapeutics and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tempest Therapeutics with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tempest Therapeutics and Aerovate Therapeutics.
Diversification Opportunities for Tempest Therapeutics and Aerovate Therapeutics
-0.82 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tempest and Aerovate is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Tempest Therapeutics and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Tempest Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tempest Therapeutics are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Tempest Therapeutics i.e., Tempest Therapeutics and Aerovate Therapeutics go up and down completely randomly.
Pair Corralation between Tempest Therapeutics and Aerovate Therapeutics
Given the investment horizon of 90 days Tempest Therapeutics is expected to under-perform the Aerovate Therapeutics. In addition to that, Tempest Therapeutics is 1.08 times more volatile than Aerovate Therapeutics. It trades about -0.12 of its total potential returns per unit of risk. Aerovate Therapeutics is currently generating about 0.26 per unit of volatility. If you would invest 210.00 in Aerovate Therapeutics on August 25, 2024 and sell it today you would earn a total of 56.00 from holding Aerovate Therapeutics or generate 26.67% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Tempest Therapeutics vs. Aerovate Therapeutics
Performance |
Timeline |
Tempest Therapeutics |
Aerovate Therapeutics |
Tempest Therapeutics and Aerovate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tempest Therapeutics and Aerovate Therapeutics
The main advantage of trading using opposite Tempest Therapeutics and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tempest Therapeutics position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. RenovoRx | Tempest Therapeutics vs. Scpharmaceuticals |
Aerovate Therapeutics vs. Eliem Therapeutics | Aerovate Therapeutics vs. HCW Biologics | Aerovate Therapeutics vs. RenovoRx | Aerovate Therapeutics vs. Scpharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |